Biodegradable Stents in Primary Sclerosing Cholangitis | MicrobiomeTrials← Back to trialsNCT07607353
Biodegradable Stents in Primary Sclerosing Cholangitis
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-03-01Est. Completion: 2027-04-01
Enrollment target: 20 participants Locations- King's College Hospital, London, London, United Kingdom
Other microbiome trials you might be interested in
Primary Sclerosing Cholangitis
This study will evaluate the effects of elafibranor (the study drug) in participants with Primary Sclerosing Cholangitis…
Lancaster, United StatesEst. completion Sep 23, 2031
Primary Sclerosing CholangitisLiver DiseasesCholangitis, Sclerosing
Primary sclerosing cholangitis (PSC) is a rare liver disease that damages the liver's bile ducts. Bile ducts are tiny tu…
Los Angeles, United StatesEst. completion May 31, 2029